| |
|
|
|
| Unsafe Drugs
:: Vioxx
|
VIOXX - The drug rofecoxib, a Cox-2 Inhibitor NSAID (nonsteroidal anti-inflammatory drug,) was FDA approved in 1999 and marketed under the brand name Vioxx by Merck & Co., Inc. Vioxx was used to treat arthritis, acute pain, fever, inflammation and menstrual cycle discomfort in adults. In 2002, Merck received approval from the FDA to market Vioxx for the treatment of migraines. A later 2004 FDA approval allowed the drug to be administered to children with rheumatoid arthritis.
In 2000, the New England Journal of Medicine reported the results of the Merck-sponsored Vioxx Gastrointestinal Outcomes Research (VIGOR) trial. The findings indicated that when administered for the same conditions, the use of Vioxx did result in a decreased risk of upper gastrointestinal toxicity but represented a five-fold increased risk of a myocardial infarction as compared to the NSAID drug, Naproxen.
The FDA sent a letter of warning to Merck in 2001 prohibiting the company from conducting any promotion for Vioxx that might minimize the serious cardiovascular events documented in the VIGOR study. A subsequent black box warning was required on Vioxx packaging, and in 2002, Merck forwarded a letter to physicians advising caution in prescribing Vioxx to certain patients.
A placebo-controlled trial sponsored by Merck called the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, was cut short in September of 2004. Intended to be a long-term study of the effects of rofecoxib on adenomatous polyps of the large intestines, the trial was abandoned because of a marked increase in heart attacks and strokes among trial participants. Those using Vioxx continually, even for as little as eighteen months, were deemed to be at greater risk of serious cardiovascular events. One day after the study was halted, Merck withdrew Vioxx from the market.
More than twenty-seven thousand separate lawsuits have been filed against Merck on behalf of those harmed by the drug. Recently, a 4.85 billion-dollar settlement was reached in a class-action lawsuit that represented approximately forty thousand plaintiffs.
The increased risk for heart attacks and strokes attributed to the use of Vioxx is well documented. Other symptoms of serious complications from the use of Vioxx may include, but are not limited to:
· Abdominal pain, nausea, discomfort or tenderness
· Bloody vomit or spontaneous bleeding
· Black, tarry or bloody stools
· Water retention or other unexplained increase in weight
· Yellowing of the eyes or skin
· Unexplained bruising
· Skin rash
· Symptoms that resemble the flu
If you or someone you know has taken Vioxx and experienced commonly recognized, or unexplained side effects, use the form below for a free evaluation with an attorney who specializes in Vioxx cases. Unsafe drug cases are complex and guidance by an attorney who is intimately familiar with the drug is crucial.
If you have safety concerns about the use of Vioxx, our free evaluation may provide important information.
Keywords: Vioxx Lawsuit | Vioxx Attorney | Vioxx Lawyer | Vioxx Attorneys | Vioxx Lawyers
|
| Free Case Evaluation |
Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.
|
| Vioxx In the News |
Avandia: Too Dangerous...but Still for Sale? - Live in the Now
Avandia: Too Dangerous...but Still for Sale?Live in the Now[link to Taking Back Your Health] Unfortunately, we have seen this before (remember Vioxx?) Big Pharma has an ugly track record of misrepresenting the truth ...and...
More Information »
NicOx Shares Tumble After FDA Turns Down Naproxcinod - BusinessWeek
NicOx Shares Tumble After FDA Turns Down NaproxcinodBusinessWeekThe FDA recommended more studies to prove the drug's safety for the heart and stomach and to show that the use of nitric oxide in the composition of the...
More Information »
Our view on Avandia: Diabetes medication dispute highlights flaws in drug ... - USA Today
Our view on Avandia: Diabetes medication dispute highlights flaws in drug ...USA TodayAs with Vioxx, the popular painkiller pulled off the market in 2004, the FDA has lagged several steps behind independent researchers. On...
More Information »
One Sign FDA Could Pull Avandia - Forbes (blog)
One Sign FDA Could Pull AvandiaForbes (blog)One bad sign for Glaxo: The amount of time being given to drug safety researcher David Graham, who played a key role in the controversies over Merck's Vioxx ...and...
More Information »
Glaxo Admits Mistakes With Paid Medical Journal Supplement - Wall Street Journal
Glaxo Admits Mistakes With Paid Medical Journal SupplementWall Street Journal... including the former pain reliever Vioxx. This isn't the first time Glaxo's Avodart marketing has been called into question. Last year...
More Information »
FDA panel's vote on Avandia reveals mixed opinions on diabetes drug's safety - Washington Post
FDA panel's vote on Avandia reveals mixed opinions on diabetes drug's safetyWashington PostFDA Commissioner Margaret A. Hamburg will make the final decision about Avandia's future. Hamburg has pledged to make drug...
More Information »
Transdel Pharma Stands to Gain From Pain Medication - Seeking Alpha (blog)
Transdel Pharma Stands to Gain From Pain MedicationSeeking Alpha (blog)As you know, Merck (MRK) lost billions of dollars in sales and put together a rescue program for patients who had trouble with Vioxx. ...Transdel...
More Information »
The Avandia Debate: Drug Company Greed or a Broken System? - AOL Health (blog)
The Avandia Debate: Drug Company Greed or a Broken System?AOL Health (blog)The fact is, many once-popular drugs have been taken off the market, including Vioxx, Pondimin, Seldane, Propulsid, Rezulin and many others that have...
More Information »
Avandia On Trial: A Plea To Weigh All The Evidence - Forbes (blog)
Avandia On Trial: A Plea To Weigh All The EvidenceForbes (blog)She has served on other panels about Vioxx, end-of-life-care, and oncology, giving her a unique perspective Many big name doctors prefer to make decisions ...and...
More Information »
Avandia controversy highlights broken pharmaceutical regulatory system - World Socialist Web Site
Avandia controversy highlights broken pharmaceutical regulatory systemWorld Socialist Web SiteAn FDA administrative hearing was held this week about cardiovascular risks relating to diabetes medication Avandia. ...and...
More Information »
Three Things To Remember During The Avandia Panel - Forbes (blog)
Three Things To Remember During The Avandia PanelForbes (blog)In 2005, a similar FDA panel was convened to discuss the fate of Merck's recalled painkiller Vioxx, which also causes heart attacks. ...
More Information »
Rosiglitazone Hearing Reveals Not-So-Rosy Rifts at FDA - MedPage Today
Rosiglitazone Hearing Reveals Not-So-Rosy Rifts at FDAMedPage Today... FDA staff reviewer David Graham, MD, known as a safety crusader since blowing the whistle on the now withdrawn anti-inflammatory drug rofecoxib (Vioxx)....
More Information »
Avandia shows need for stronger FDA - DesMoinesRegister.com
Avandia shows need for stronger FDADesMoinesRegister.comIt's not the first time concerns about an FDA-approved product came to light - after scores of Americans were using it. Think Vioxx for increasing ...and...
More Information »
Avandia on Trial - PharmExec.com (blog)
PharmExec.com (blog)Avandia on TrialPharmExec.com (blog)Both made their names a decade ago leading the charge against Vioxx, and the Avandia dustup has further burnished their reputations as anti-pharma crusaders ...and...
More Information »
Drug Company Accused of Hiding Hazards - The Epoch Times
Drug Company Accused of Hiding HazardsThe Epoch TimesIt concerned the drug company Merck's burying of data regarding the safety of its painkilling drug rofecoxib (Vioxx). I find it depressing and saddening ...
More Information »
Safety of diabetes drug Avandia debated by federal scientists - Washington Post
Safety of diabetes drug Avandia debated by federal scientistsWashington PostSales of Avandia plummeted, and the FDA issued strong new warnings about the drug's safety. But after a panel of advisers voted later that year...
More Information »
Defending Fish Oil, Criticizing Glaxo - Forbes (blog)
Defending Fish Oil, Criticizing GlaxoForbes (blog)It's a nice trick: they have almost no downside, since fish oil is almost certain not to cause the bad side effects we saw with Vioxx (for example). ...and...
More Information »
GlaxoSmithKline's Avandia Is Back Under FDA Scrutiny Over Cardiac Risks - DailyFinance
GlaxoSmithKline's Avandia Is Back Under FDA Scrutiny Over Cardiac RisksDailyFinanceHe also reminds us how in 2005, a similar FDA panel on Merck's (MRK) recalled drug Vioxx voted in favor of returning it to the market....
More Information »
FDA advisory panel recommends keeping Avandia on the market with additional ... - Examiner.com
Examiner.comFDA advisory panel recommends keeping Avandia on the market with additional ...Examiner.comAfter two days of hearings the 33 members of the FDA's advisory panel voted to allow Avandia to stay on the market....
More Information »
Mother: Marijuana Helps Son Cope with Severe OCD - Opposing Views
Opposing ViewsMother: Marijuana Helps Son Cope with Severe OCDOpposing Views... placebo-controlled studies by the FDA. (You know, those studies that brought us such safe and effective drugs as thalidomide, fen phen, and...
More Information »
Glaxo settles Avandia lawsuits - Investor's Business Daily
Glaxo settles Avandia lawsuitsInvestor's Business DailyDavid Graham and the tragedy of Vioxx parts I and II discuss in part I, some of the culture at FDA and in part II the specifics of what occured with the ...
More Information »
Avandia On Trial: Glaxo's Cardinal Sin of Bad Data - Forbes (blog)
Avandia On Trial: Glaxo's Cardinal Sin of Bad DataForbes (blog)During the Vioxx controversy five years ago, there were randomized clinical trials showing a heart risk for both Merck's Vioxx and Pfizer's Bextra....
More Information »
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More - BNET
BNETBiotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and MoreBNETPA) naproxcinod: This arthritis drug, which is aiming to be a safer version of Vioxx, already got rejected by an advisory panel. An FDA...
More Information »
Avandia Hearing Reveals Fundamental Flaws at FDA - Union of Concerned Scientists
Avandia Hearing Reveals Fundamental Flaws at FDAUnion of Concerned Scientists“Over the past five years, FDA scientists who have questioned the safety of drugs such as Avandia, Vioxx and Ketek were not only were ignored, ...
More Information »
Eco Etiquette: Is It Safe To Eat Gulf Seafood? - Huffington Post (blog)
Eco Etiquette: Is It Safe To Eat Gulf Seafood?Huffington Post (blog)Like Vioxx. Or the toxic chemical BPA, which FDA originally ruled to be risk-free in food packaging before it reversed its stance early this year. ...and...
More Information »
FDA hearings set for diabetes drug Avandia - CNN
CNNFDA hearings set for diabetes drug AvandiaCNN... in the willing suspension of disbelief," said Dr. David Graham, the FDA scientist who first flagged deadly side effects of the painkiller Vioxx. ...
More Information »
Instant view: US advisers say keep Glaxo's Avandia on market - Reuters
Instant view: US advisers say keep Glaxo's Avandia on marketReutersAfter Vioxx people naturally are nervous about taking medications because they're fearful of potential safety issues. Allowing this drug to remain on...
More Information »
Advierten sobre consumo de Avandia para la diabetes - Siglo21
Advierten sobre consumo de Avandia para la diabetesSiglo21El creciente cúmulo de evidencias, y la respuesta de la FDA en evolución, hace una reminiscencia de la controversia que condujeron a la retirada de Vioxx ...
More Information »
|
|
| |